Literature DB >> 21887462

Bufotalin sensitizes death receptor-induced apoptosis via Bid- and STAT1-dependent pathways.

Pornthip Waiwut1, Akiko Inujima, Hiroki Inoue, Ikuo Saiki, Hiroaki Sakurai.   

Abstract

Tumor necrosis factor-alpha (TNF-α) and TNF-related apoptosis-inducing ligand (TRAIL) are apoptosis-inducing ligands that stimulate death receptors. In this study, we investigated the effects of bufotalin, a major compound in toad venom, on sensitizing TNF-α and TRAIL-induced apoptosis of HeLa cells. Bufotalin promoted death receptor-mediated cell death, especially TRAIL-induced apoptosis, through activation of caspase-3 and PARP-1. Mitochondrial Bid-dependent pathway was activated in TNF-α-induced cell death. Cotreatment of bufotalin with TRAIL resulted in the downregulation of anti-apoptotic proteins, including Bcl-XL, Mcl-1, survivin and XIAP, and the up-regulation of MAPKs and TRAIL receptor DR5. In addition, phosphorylation of STAT1 was strongly inhibited by bufotalin. Moreover, DR5 expression was induced by knocking down the STAT1 expression. Moreover, the TRAIL-induced apoptotic response was promoted by STAT1 siRNA. Our results demonstrated that bufotalin is a powerful sensitizer of death receptor-induced apoptosis in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21887462     DOI: 10.3892/ijo.2011.1182

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Ethanolic extract of Thevetia peruviana flowers enhances TNF-α and TRAIL-induced apoptosis of human cervical cancer cells via intrinsic and extrinsic pathways.

Authors:  Chittima Managit; Hiroaki Sakurai; Ikuo Saiki
Journal:  Oncol Lett       Date:  2017-02-17       Impact factor: 2.967

2.  Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway.

Authors:  Jia Liu; Leina Ma; Ning Wu; Ge Liu; Lanhong Zheng; Xiukun Lin
Journal:  Mar Drugs       Date:  2014-09-25       Impact factor: 5.118

3.  Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450.

Authors:  C Cerella; F Muller; A Gaigneaux; F Radogna; E Viry; S Chateauvieux; M Dicato; M Diederich
Journal:  Cell Death Dis       Date:  2015-06-11       Impact factor: 8.469

4.  Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice.

Authors:  Xiaohe Li; Zhun Bi; Shuaishuai Liu; Shaoyan Gao; Yunyao Cui; Kai Huang; Mengying Huang; Jiahe Mao; Lixin Li; Jingjing Gao; Tao Sun; Honggang Zhou; Cheng Yang
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

Review 5.  A research update on the antitumor effects of active components of Chinese medicine ChanSu.

Authors:  Jinhao Jia; Jie Li; Qiusheng Zheng; Defang Li
Journal:  Front Oncol       Date:  2022-09-27       Impact factor: 5.738

6.  Immunomodulatory Effects of Cinobufagin on Murine Lymphocytes and Macrophages.

Authors:  Yang Yu; Hui Wang; Xianhua Meng; Lu Hao; Yue Fu; Linlin Fang; Dan Shen; Xiaomeng Yu; Jingshung Li
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-19       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.